Interleukin-2 appeared to be effective for controlling the effusion, however, systemic chemotherapy with docetaxel plus oxaliplatin, followed with gemcitabine plus cisplatin, appeared non-effective and the patient exhibited disease progression with involvement of the central nervous system, indicating the refractory entity and poor prognosis of this type of carcinoma. The gene discussed is IL2; the disease is carcinoma.